Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,000Revenue (TTM) $M169Net Margin (%)-35.0Altman Z-Score-0.9
Enterprise Value $M2,213EPS (TTM) $-0.3Operating Margin %-99.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-36.1Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsN
Price/Sales11.75-y EBITDA Growth Rate %--Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-10.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M193ROIC % (ttm)-140.4Gross Margin Increase y-yY

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ARIAMichael Price 2016-03-31 Add0.23%$4.48 - $6.66
$ 10.3885%Add 31.10%1,075,000
ARIAMichael Price 2015-12-31 Add0.08%$5.78 - $7.19
$ 10.3858%Add 14.45%820,000
ARIAMichael Price 2015-09-30 Add0.15%$5.81 - $9.89
$ 10.3835%Add 30.27%716,500
ARIAJoel Greenblatt 2015-06-30 Sold Out $7.9 - $9.71
$ 10.3818%Sold Out0
ARIAMichael Price 2015-03-31 Buy 0.6%$6.1 - $8.97
$ 10.3840%New holding550,000
ARIAJoel Greenblatt 2015-03-31 Buy $6.1 - $8.97
$ 10.3840%New holding16,344
ARIAGeorge Soros 2014-12-31 Sold Out -0.01%$5.02 - $7.46
$ 10.3865%Sold Out0
ARIAGeorge Soros 2014-09-30 Reduce-0.04%$5.01 - $6.5
$ 10.3878%Reduce -85.00%150,000
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
$ 10.3851%Add 100.00%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
$ 10.3834%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
$ 10.38101%New holding1,950,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
$ 10.38-37%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
$ 10.38-24%New holding635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
$ 10.38-5%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
$ 10.38-2%New holding496,847
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bollag Daniel MSr. VP, Reg. Affairs & Quality 2016-10-03Sell47,384$13.46-22.88view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-28Sell8,750$13.98-25.75view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-22Sell20,000$13.43-22.71view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-09-15Sell59,369$11.73-11.51view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-22Sell19,436$10.47-0.86view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-12Sell25,000$10.5-1.14view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-07-22Sell18,286$8.1127.99view
Cole Hugh MSVP, Chief Business Officer 2016-06-28Sell6,012$7.0547.23view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-06-22Sell23,999$7.2842.58view
LAVIDAS ATHANESEDirector 2016-06-15Sell76,250$8.2126.43view

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Michael Price Invests in 11 Companies in First Quarter May 19 2015 
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 10 2009 
Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Aug 08 2009 

More From Other Websites
Ariad May Not Be the Last to Feel the Bern Oct 21 2016
Washington's next biotech target? Oct 20 2016
ARIAD Reaffirms Commitment to Discovering and Developing Treatments for Patients with Rare Cancers Oct 20 2016
Why Ariad Pharmaceuticals (ARIA) Stock Is Sliding Today Oct 20 2016
Sanders Follows Ariad Tweet With Document Request on Pricing Oct 20 2016
Bernie Sanders Follows ‘Greed’ Tweet on Ariad With Letter Oct 20 2016
Ariad cancer drug pricing under congressional scrutiny Oct 20 2016
Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold Oct 19 2016
Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential Oct 18 2016
California's drug pricing bill Oct 17 2016
Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad Oct 17 2016
ARIAD Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARIA-US :... Oct 17 2016
Here’s Why These Five Stocks Are in the Spotlight Oct 15 2016
Martin Shkreli trial set for June Oct 14 2016
Why Ariad (ARIA) Stock Is Plunging Today Oct 14 2016
Sanders’ Tweet on Drugmaker Ariad’s ‘Greed’ Sends Stock Plunging Oct 14 2016
Bernie Sanders just called out a drug company for jacking up the price of its leukemia drug — and... Oct 14 2016
Will These 5 Drug Stocks Be Big Winners This Earnings Season? Oct 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)